Emerging infectious diseases · 2021 · 75 citations · 6 references
Veterinary MedicineInfectious DiseasesPediatricsAdolescent HealthImmunizationVaccinologyPediatric ImmunizationVaccinationVaccine DevelopmentVaccine EffectivenessVaccine EfficacyVaccine-preventable DiseasesCoronavirus VaccinesOverall Vaccine EffectivenessPediatric VaccinationPediatric Vaccine EfficacySars-cov-2 InfectionSeasonal Vaccine EffectivenessVaccination Policy For AdolescentsVariant-specific Vaccine Effectiveness
In Israel, the BNT162b2 vaccine against severe acute respiratory syndrome coronavirus 2 was approved for use in adolescents in June 2021, shortly before an outbreak of B.1.617.2 (Delta) variant-dominant infection. We evaluated short-term vaccine effectiveness and found the vaccine to be highly effective among this population in this setting.
6